Immunosuppression in kidney transplantation

These last years, major progress in renal transplantation were observed, especially in immunosuppression with new drugs available. In the first part of this paper, immunological process of allogenic response is described. Then, the different classes of immunosuppressive drugs, their potential associ...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Progrès en urologie (Paris) 2011-04, Vol.21 (4), p.250-253
Hauptverfasser:	Balssa, L, Bittard, H, Kleinclauss, F
Format:	Artikel
Sprache:	fre
Schlagworte:	Abatacept Anti-Inflammatory Agents - therapeutic use Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Antilymphocyte Serum - therapeutic use Calcineurin Inhibitors Humans Immunoconjugates - therapeutic use Immunoglobulin G - therapeutic use Immunosuppression Immunosuppressive Agents - therapeutic use IMP Dehydrogenase - antagonists & inhibitors Kidney Transplantation Recombinant Fusion Proteins - therapeutic use TOR Serine-Threonine Kinases - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	These last years, major progress in renal transplantation were observed, especially in immunosuppression with new drugs available. In the first part of this paper, immunological process of allogenic response is described. Then, the different classes of immunosuppressive drugs, their potential associations and new trends in immunosuppression are presented.
ISSN:	1166-7087
DOI:	10.1016/j.purol.2010.08.048